AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: FYCOMPA (Catalyst Pharmaceuticals) (fycompa.com)
FYCOMPA is a textbook example of regulatory-driven substance masked by a high-gloss marketing metaphor. The score remains low because pharmaceutical compliance mandates a floor of substance that most industries lack, though the stale patient data and ‘road trip’ fluff are clear BS signals. It is a professionally built site where the bullshit is primarily found in the forced optimism of its navigational metaphors.
Update all patient usage statistics (400,000 worldwide) to reflect data from the last 12 months to eliminate the ‘stale data’ penalty. Replace the navigational ‘road trip’ metaphors in H2 headings with substantive descriptors like ‘Seizure Management Protocols’ or ‘Caregiver Resource Center.’ Add a ‘Clinical Leadership’ section to the About page with links to the peer-reviewed studies supporting the AMPA receptor findings. Explicitly link the review_count metadata to a verified third-party patient experience platform.
Information density is split between high-substance regulatory text and high-fluff marketing metaphors. While the ISI blocks provide granular technical detail, the headings across the Tools and Support page rely heavily on a ‘road trip’ metaphor (Welcome to your road trip, Make time for rest stops, Missed your exit?) that lacks medical noun-density. The body substance ratio is salvaged by the inclusion of specific technical protocols like the AMPA receptor target and age-specific indications (4 years+ and 12 years+).
A validator checks markup; an AI audit checks comprehension. Start your free one page AI interpretation to see how your structured data is actually interpreted by LLMs.
There is minimal semantic drift between the homepage signal and the sub-page content. The homepage H1 ‘FYCOMPA is still available’ serves as a defensive market signal against generics, which is successfully supported by the Patient Stories and Tools pages that emphasize brand-specific support ecosystems. Cross-page messaging remains consistent, focusing on the transition from breakthrough seizures to controlled outcomes.
Identify the current state and friction diagnosis of your specific business model. Generate your Executive SEO Strategy to quantify the financial or conversion cost of strategic misalignment.
The site exhibits Trust Theatre through the metadata reporting review counts (e.g., review_count 7 on Tools & Support) while the body text provides zero verified review links or third-party proof paths. Furthermore, the claim of 400,000 patients worldwide is pinned to a ‘March 2021’ date; as of the May 2026 temporal anchor, this data is 62 months old (stale) and has not been updated to reflect current usage, creating a reliability gap.
Proof density is moderate; the site successfully provides a clear Prescribing Information PDF link and detailed dosage instructions for missed exits. However, the ratio of marketing fluff (road trip imagery) to verifiable clinical evidence is skewed by the age of the patient data (2021). The presence of structured schema for the drug perampanel increases the technical credibility significantly compared to non-pharma health sites.
To see how the system reconstructs a medical entity graph at scale, review the full Cleveland Clinic Structured Data audit. View the Cleveland Clinic Structured Data Audit for a live example of identity level decomposition and cross page entity mapping.
The site uses a ‘road trip’ theme to differentiate its patient resources, which is a unique positioning effort in an otherwise boilerplate industry. However, it still falls into generic pharma clichés such as ‘committed to supporting you every step of the way’ and ‘epilepsy does not define me.’ The site structure follows the standard template_fingerprints for patient-facing drug portals (Patient Stories, Tools & Support, Medication Guide).
Authority is primarily corporate (Catalyst Pharmaceuticals) rather than individual. While the schema_json includes detailed MedicalCondition and Drug entities, there is a total absence of named Medical Advisory Boards or Key Opinion Leaders (KOLs) within the text. The reliance on patient stories like Leslie and Nick provides emotional authority but leaves a gap in current clinical leadership representation.
The site makes performance claims such as ‘some patients taking FYCOMPA experienced fewer seizures,’ but the substance is relegated to footnotes stating ‘Individual results may vary.’ There is a disconnect between the optimistic ‘life full of adventure’ marketing tone and the heavy, mandatory safety warnings that occupy roughly 50% of the page real estate. No specific clinical trial data tables or peer-reviewed citations are visible in the crawled text to back the 1 in 500 suicidal thoughts metric.
Medical Devices, Pharma & Biotech BS: FYCOMPA (Catalyst Pharmaceuticals) (fycompa.com)
The site perfectly aligns with the Pharma & Biotech industry category. It provides high-substance medical indications, mechanism of action (AMPA receptor targeting), and extensive Important Safety Information (ISI) required for prescription drugs.
Every pillar of machine readability depends on one foundation: explicit, verifiable entity definitions. Explore the Structured Data Technical Framework to understand how identity, relationships, and @id anchors form the base layer of AI interpretation.
“The score of 36 is primarily driven by Information Density (metaphor fluff) and Trust Theatre (stale data and unverified review counts). The score is kept low by the excellent technical implementation of schema_json and the mandatory substance of the ISI sections. Semantic coherence is high, indicating a well-aligned but highly-marketed brand presence.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 30, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at FYCOMPA (Catalyst Pharmaceuticals) to view the most current version of their content and see directly what the company offers.